Evidence map›Paper›PMID 15388875›Full record

ArticleRNA (New York, N.Y.)2004

Cap-binding activity of an eIF4E homolog from Leishmania.

Yael Yoffe, Joanna Zuberek, Magdalena Lewdorowicz, Ziv Zeira, Chen Keasar, Irit Orr-Dahan, Marzena Jankowska-Anyszka, Janusz Stepinski, Edward Darzynkiewicz, Michal Shapira

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. LeishIF3d is a non-canonical cap-binding protein inFrontiers in molecular biosciences · 2023
    Article
  4. Article
  5. Article
  6. Characterization of an Atypical eIF4E Ortholog inInternational journal of molecular sciences · 2021
    Article
  7. LeishIF4E-5 Is a Promastigote-Specific Cap-Binding Protein inInternational journal of molecular sciences · 2021
    Article
  8. Review
  9. Biomolecular NMR assignments · 2020
    Article
  10. Article
  11. Article
  12. Analysis of the Antigenic and Prophylactic Properties of theFrontiers in cellular and infection microbiology · 2018
    Article
  13. Review
  14. Article
  15. Distinct features of cap binding by eIF4E1b proteins.Journal of molecular biology · 2015
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Yael YoffeDepartment of Life Sciences, Ben-Gurion University of the Negev, P.O.B. 653, Beer Sheva 84105, Israel.
Joanna Zuberek
Magdalena Lewdorowicz
Ziv Zeira
Chen Keasar
Irit Orr-Dahan
Marzena Jankowska-Anyszka
Janusz Stepinski
Edward Darzynkiewicz
Michal Shapira
Ben-Gurion University of the Negev · ILUniversity of Warsaw · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

All eukaryotic mRNAs possess a 5'-cap (m(7)GpppN) that is recognized by a family of cap-binding proteins. These participate in various processes, such as RNA transport and stabilization, as well as in assembly of the translation initiation complex. The 5'-cap of trypanosomatids is complex; in addition to 7-methyl guanosine, it includes unique modifications on the first four transcribed nucleotides, and is thus denoted cap-4. Here we analyze a cap-binding protein of Leishmania, in an attempt to understand the structural features that promote its binding to this unusual cap. LeishIF4E-1, a homolog of eIF4E, contains the conserved cap-binding pocket, similar to its mouse counterpart. The mouse eIF4E has a higher K(as) for all cap analogs tested, as compared with LeishIF4E-1. However, whereas the mouse eIF4E shows a fivefold higher affinity for m(7)GTP than for a chemically synthesized cap-4 structure, LeishIF4E-1 shows similar affinities for both ligands. A sequence alignment shows that LeishIF4E-1 lacks the region that parallels the C terminus in the murine eIF4E. Truncation of this region in the mouse protein reduces the difference that is observed between its binding to m(7)GTP and cap-4, prior to this deletion. We hypothesize that variations in the structure of LeishIF4E-1, possibly also the absence of a region that is homologous to the C terminus of the mouse protein, promote its ability to interact with the cap-4 structure. LeishIF4E-1 is distributed in the cytoplasm, but its function is not clear yet, because it cannot substitute the mammalian eIF4E in a rabbit reticulocyte in vitro translation system.

Indexed as

Amino Acid SequenceAnimalsCells, CulturedComputer SimulationConserved SequenceCytoplasmEukaryotic Initiation Factor-4EFluorescent Antibody Technique, IndirectGuanosine DiphosphateKineticsLeishmaniaLeishmania majorMicroscopy, FluorescenceModels, MolecularMolecular Sequence DataProtein Structure, SecondaryEukaryotic Initiation Factor-4EGuanosine DiphosphateRecombinant ProteinsRNA Cap-Binding ProteinsRNA, Protozoan

Identifiers

PMID15388875
PMCPMC1370664
OpenAlexW2105141777

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.